GlassScriptPhysician profile
Amy L Heusinger
NPI 1801194584
$7,682.81
in general payments reported to CMS, 2019-2025
46 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,583 · 2022: $1,366 · 2023: $1,970 · 2024: $2,290 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,733.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,164.57 | 2021-2025 | Enbrel, Otezla, Tavneos |
| Collegium Pharmaceutical, INC. | $817.94 | 2021-2025 | Xtampza, Belbuca |
| Janssen Biotech, INC. | $609.48 | 2022-2025 | Tremfya, Simponi Aria, Remicade |
| Nevro Corp. | $586.56 | 2021-2024 | Senza |
| Abbvie INC. | $580.41 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $414.56 | 2022-2025 | Purified Cortrophin Gel |
| Radius Health, INC. | $290.19 | 2023-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.83 | 2022-2024 | Ofev |
| Ucb, INC. | $275.14 | 2022-2025 | Cimzia, Bimzelx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $242.89 | 2021-2023 | Relistor |
| Biohaven Pharmaceuticals, INC. | $241.25 | 2021 | |
| Forte Bio-Pharma LLC | $194.43 | 2021-2022 | |
| Fresenius Kabi USA, LLC | $153.00 | 2024-2025 | Idacio |
| Grt US Holding, INC. | $138.23 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $127.48 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Heusinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.